Convenience - The fully remote model eliminates the need for in-person appointments, pharmacy visits, or navigating insurance authorization processes
Abstract This study assessed the effect of GLP-1 based therapies on atherosclerotic markers in type 2 diabetes patients
Conclusion After a temporary slowdown, FDA has resumed aggressive, batchstyle enforcementagain targeting how compounded GLP1 products are marketed through telehealth channels
An agent told me, Regarding compounded semaglutide, we are still providing it at this time, and we have not received any updates indicating supply issues or an expected shortage in the near future. If you decide to take compounded GLP-1 medication, there is a possibility that MedVi (or any telehealth provider) can run out of its supply and no longer provide medication
Theres no major rush
Wegovy, a semaglutide, is also available as a tablet taken orally once daily